Alternative Immunotherapy in Breast Cancer by SiCORE-CIT

Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT) has published an article about alternative immunotherapy in breast cancer “Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer” on the world-renowned journal Molecular Cancer Therapeutics Volume 21, Issue 5, May 1st, 2022 (https://doi.org/10.1158/1535-7163.mct-21-0823).

Molecular Cancer Therapeutics is a journal published on translational research studies focused on the discovery and preclinical development of therapeutic agents for oncology.